Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Equillium, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 25 | 30 | +5 |
| Shares | 12.6M | 12.9M | +269.5K (+2.1%) |
| Value | $25.6M | $28.4M | +$2.84M (+11.1%) |
New holders (5)
Institutions that held Equillium, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 24,141 | $54.0K | 0.00% |
| Integrated Wealth Concepts LLC | 20,000 | $44.0K | 0.00% |
| Dimensional Fund Advisors LP | 19,564 | $43.0K | 0.00% |
| Kistler-Tiffany Companies, LLC | 2,000 | $4.00K | 0.00% |
| Royal Bank of Canada | 111 | $0 | 0.00% |
Sold out (0)
Institutions that held Equillium, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
None.